Synergism for cytokine-mediated disease during concurrent endotoxin and viral challenges: Roles for NK and T cell IFN-γ production

Journal of Immunology

Volumn 162, Issue 9, 1999, Pages 5238-5246

  Nguyen, Khuong B ^a   Biron, Christine A ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; GAMMA INTERFERON; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION REGULATION; IMMUNOPHENOTYPING; INFECTION PREVENTION; INFECTION SENSITIVITY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CYTOKINES; DRUG SYNERGISM; FEMALE; INJECTIONS, INTRAPERITONEAL; INTERFERON TYPE II; INTERLEUKIN-12; KILLER CELLS, NATURAL; LIPOPOLYSACCHARIDES; LYMPHOCYTE SUBSETS; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, NUDE; MICE, SCID; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033137047     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Dinarello, C. A. 1996. Cytokines as mediators in the pathogenesis of septic shock. Curr. Top. Microbiol. Immunol. 216:133.
2. Gutierrez-Ramos, J. C., and H. Bluethmann. 1997. Molecules and mechanisms operating in septic shock: lessons from knockout mice. Immunol. Today 18:329.
3. Beutler, B. A., I. W. Milsark, and A. Cerami. 1985. Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. J. Immunol. 135:3972.
4. Ozmen, L., M. Pericin, J. Hakimi, R. A. Chizzonite, M. Wysocka, G. Trinchieri, M. Gately, and G. Garotta. 1994. Interleukin 12, Interferon γ, and tumor necrosis factor α are the key cytokines of the generalized Shwartzman reaction. J. Exp. Med. 180:907.
5. Heinzel, F. P., R. M. Rerko, P. Ling, J. Hakimi, and D. S. Schoenhaut. 1994. Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of γ interferon. Infect. Immun. 62:4244.
6. Wysocka, M., M. Kubin, L. Q. Vieira, L. Ozmen, G. Garotta, P. Scott, and G. Trinchieri. 1995. Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol. 25:672.
7. Beutler, B., I. W. Milsark, and A. C. Cerami. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:869.
8. Pfeffer, K., T. Matsuyama, T. M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P. S. Ohashi, M. Kronke, and T. W. Mak. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457.
9. Billiau, A., H. Heremans, F. Vandekerckhove, and C. Dillen. 1987. Anti-interferon-γ antibody protects mice against the generalized Shwartzman reaction. Eur. J. Immunol. 17:1851.
10. Heremans, H., J. Van Damme, C. Dillen, R. Dijkmans, and A. Billiau. 1990. Interferon γ, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice. J. Exp. Med. 171:1853.
11. Heinzel, F.P. 1990. The role of IFN-γ in the pathology of experimental endotoxemia. J. Immunol. 145:2920.
12. Doherty, G. M., J. R. Lange, H. N. Langstein, H. R. Alexander, C. M. Buresh, and J. A. Norton. 1992. Evidence for IFN-γ as a mediator of the lethality of endotoxin and tumor necrosis factor-α. J. Immunol. 149:1666.
13. Car, B. D., V. M. Eng, B. Schnyder, L. Ozmen, S. Huang, P. Gallay, D. Heumann, M. Aguet, and B. Ryffel. 1994. Interferon γ receptor deficient mice are resistant to endotoxic shock. J. Exp. Med. 179:1437.
14. Lehmann, V., M. A. Freudenberg, and C. Galanos. 1987. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J. Exp. Med. 165:657.
15. Kettelhut, I. C., W. Fiers, and A. L. Goldberg. 1987. The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors. Proc. Natl. Acad. Sci. USA 84:4273.
16. Starnes, H. F., Jr., R. S. Warren, M. Jeevanandam, J. L. Gabrilove, W. Larchian, H. F. Oettgen, and M. F. Brennan. 1988. Tumor necrosis factor and the acute metabolic response to tissue injury in man. J. Clin. Invest. 82:1321.
17. Aggarwal, B. B., T. E. Eessalu, and P. E. Mass. Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon. Nature 318: 665.
18. Tsujimoto, M., Y. K. Yip, and J. Vilcek. 1986. Interferon-γ enhances expression of cellular receptors for tumor necrosis factor. J. Immunol. 136:2441.
19. Beutler, B., D. Greenwald, J. D. Hulmes, M. Chang, Y. C. Pan, J. Mathison, R. Ulevitch, and A. Cerami. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 316:552.
20. Heinzel, F. P., R. M. Rerko, F. Ahmed, and A. M. Hujer. 1996. IFN-γ-independent production of IL-12 during murine endotoxemia. J. Immunol. 157:4521.
21. Verhasselt, V., C. Buelens, F. Willems, D. De Groote, N. Haeffner-Cavaillon, and M. Goldman. 1997. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway. J. Immunol. 158:2919.
22. Sousa, C. R., S. Hieny, T. Scharton-Kersten, D. Jankovic, H. Charest, R. N. Germain, and A. Sher. 1997. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med. 186:1819.
23. + T cells and their IFN-γ production in the generalized Shwartzman reaction. J. Immunol. 160:3522.
24. Biron, C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens, and T. P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17:189.
25. Heremans, H., C. Dillen, J. van Damme, and A. Billiau. 1994. Essential role for natural killer cells in the lethal lipopolysaccharide-induced Shwartzman-like reaction in mice. Eur. J. Immunol. 24:1155.
26. Ruzek, M. C., A. H. Miller, S. M. Opal, B. D. Pearce, and C. A. Biron. 1997. Characterization of early cytokine responses and an interleukin (IL)-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection. J. Exp. Med. 185:1185.
27. Coutelier, J. P., J. Van Broeck, and S. F. Wolf. 1995. Interleukin-12 gene expression after viral infection in the mouse. J. Virol. 69:1955.
28. Trgovcich, J., K. Ryman, P. Extrom, J. C. Eldridge, J. F. Aronson, and R. E. Johnston. 1997. Sindbis virus infection of neonatal mice results in a severe stress response. Virology 227:234.
29. Kanangat, S., J. Thomas, S. Gangappa, J. S. Babu, and B. T. Rouse. 1996. Herpes simplex virus type 1-mediated up-regulation of IL-12 (p40) mRNA expression: implications in immunopathogenesis and protection. J. Immunol. 156:1110.
30. Monteiro, J. M., C. Harvey, and G. Trinchieri. 1998. Role of interleukin-12 in primary influenza virus infection. J. Virol. 72:4825.
31. Orange, J. S., T. P. Salazar-Mather, S. M. Opal, and C. A. Biron. 1997. Mechanisms for virus-induced liver disease: tumor necrosis factor-mediated pathology independent of natural killer and T cells during murine cytomegalovirus infection. J. Virol. 71:9248.
32. Ruzek, M. C., B. D. Bearce, A. H. Miller, and C. A. Biron. 1999. Endogenous glucocorticoids protect against cytokine-mediated lethality during viral infection. J. Immunol. 162:3527.
33. Ray, G. C. 1994. Influenza, respiratory syncytial virus, adenovirus, and other respiratory viruses. In Sherris Medical Microbiology: An introduction to Infectious Diseases, 3rd Ed. K. J. Ryan, ed. Appleton and Lange Paramount Publishing Business and Professional Group, East Norwalk. CT, p. 456.
34. Murray, P. R., K. S. Rosenthal, G. S. Kobayashi, and M. A. Pfaller. 1998. Orthomyxoviruses. In Medical Microbiology, 3rd Ed. M. Brown, ed. Mosby-Year Book, St. Louis, p. 477.
35. Degre, M., and L. A. Glasgow. 1968. Synergistic effect in viral-bacterial infection. I. Combined infection of the respiratory tract in mice with parainfluenza virus and Hemophilus influenza. J. Infect. Dis. 118:449.
36. Jones, W. T., J. H. Menna, and D. E. Wennerstrom. 1983. Lethal synergism induced in mice by influenza type A virus and type Ia group B streptococci. Infect. Immun. 41:618.
37. Zhang, W. J., S. Sarawar, P. Nguyen, K. Daly, J. E. Rehg, P. C. Doherty, D. L. Woodland, and M. A. Blackman. 1996. Lethal synergism between influenza infection and staphylococcal enterotoxin B in mice. J. Immunol. 157:5049.
38. Sarawar, S. R., M. A. Blackman, and P. C. Doherty. 1994. Superantigen shock in mice with an inapparent viral infection. J. Infect. Dis. 170:1189.
39. Nansen, A., J. P. Christensen, O. Marker, and A. R. Thomsen. 1997. Sensitization to lipopolysaccharide in mice with asymptomatic viral infection: role of T cell-dependent production of interferon-γ. J. Infect. Dis. 176:151.
40. Lane, J. R., D. A. Neumann, A. Lafond-Walker, A. Herskowitz, and N. R. Rose. 1991. LPS promotes CB3-induced myocarditis in resistant B10.A mice. Cell. Immunol. 136:219.
41. Leung, W. C., and K. Hashimoto. 1986. Modification of susceptibility to Klebsiella pneumoniae during murine cytomegalovirus infection. Microbiol. Immunol. 30:761.
42. Bale, J. F., Jr., E. R. Kern, J. C. Overall, Jr., and L. A. Glasgow. 1982. Enhanced susceptibility of mice infected with murine cytomegalovirus to intranasal challenge with Escherichia coli: pathogenesis and altered inflammatory response. J. Infect. Dis. 145:525.
43. Pullen, L. C., S. H. Park, S. D. Miller, M. C. Dal Canto, and B. S. Kim. 1995. Treatment with bacterial LPS renders genetically resistant C57BL/6 mice susceptible to Theiler's virus-induced demyelinating disease. J. Immunol. 155:4497.
44. Orange, J. S., S. F. Wolf, and C. A. Biron. 1994. Effects of IL-12 on the response and susceptibility to experimental viral infections. J. Immunol. 152:1253.
45. Orange, J. S., T. P. Salazar-Mather, S. M. Opal, R. L. Spencer, R. L., A. H. Miller, B. S. McEwen, and C. A. Biron. 1995. Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids. J. Exp. Med. 181:901.
46. Orange, J. S., and C. A. Biron. 1996. An absolute and restricted requirement for IL-12 in natural killer cell IFN-γ production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J. Immunol. 156:1138.
47. Biron, C. A., H. C. Su, and J. S. Orange. 1996. Function and regulation of natural killer (NK) cells during viral infections: characterization of responses in vivo. Methods 9:379.
48. Biron, C. A., K. F. Pedersen, and R. M. Welsh. 1987. Aberrant T cells in beige mutant mice. J. Immunol. 138:2050.
49. Cousens, L. P., J. S. Orange, and C. A. Biron. 1995. Endogenous IL-2 contributes to T cell expansion and IFN-γ production during lymphocytic choriomeningitis virus infection. J. Immunol. 155:5690.
50. Lau, L. L., B. D. Jamieson, T. Somasundaram, and R. Ahmed. 1994. Cytotoxic T-cell memory without antigen. Nature 369:648.
51. Butz, E. A., and M. J. Bevan. 1998. Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity 8:167.
52. Murali-Krishna, K., J. D. Altman, M. Suresh, D. J. Sourdive, A. J. Zajac, J. D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177.
53. + T cell interactions in IFN-γ and IL-4 responses to viral infections: requirements for IL-2. J. Immunol. 160:5007.
54. Mombaerts, P., J. Iacomini, R. S. Johnson, K. Herrup, S. Tonegawa, and V. E. Papaioannou. 1992. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68:869.
55. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259:1739.
56. Wang, B., C. Biron, J. She, K. Higgins, M. J. Sunshine, E. Lacy, N. Lonberg, and C. Terhorst. 1994. A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3∈ gene. Proc. Natl. Acad. Sci. USA 91:9402.
57. 2-microglobulin-deficient mice. J. Immunol. 153:5674.
58. Suitters, A. J., R. Foulkes, S. M. Opal, J. E. Palardy, J. S. Emtage, M. Rolfe, S. Stephens, A. Morgan, A. R. Holt, L. C. Chaplin, N. E. Shaw, A. M. Nesbitt, and M. W. Bodmer. 1994. Differential effect of isotype on efficacy of anti-tumor necrosis factor a chimeric antibodies in experimental septic shock. J. Exp. Med. 179:849.
59. Orange, J. S., B. Wang, C. Terhorst, and C. A. Biron. 1995. Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182:1045.
60. O'Garra, A., and K. W. Murphy. 1996. Role of cytokines in determining T cell function (mouse). In Weir's Handbook of Experimental Immunology, 5th Ed. D. M. Weir, ed, Blackwell Science, Cambridge, U.K., p. 2261.
61. Orange, J. S., and C. A. Biron. 1996. Characterization of early IL-12, IFN-αβ, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 156:4746.
62. Su, H. C., K. A. Leite-Morris, L. Braun, and C. A. Biron. 1991. A role for transforming growth factor-β1 in regulating natural killer cell and T lymphocyte proliferative responses during acute infection with lymphocytic choriomeningitis virus. J. Immunol. 147:2717.
63. Su, H. C., R. Ishikawa, and C. A. Biron. 1993. Transforming growth factor-β expression and natural killer cell responses during virus infection of normal, nude, and SC1D mice. J. Immunol. 151:4874.